Imagen de Portada

Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors

Liver resection (LR) within a multimodal treatment concept of hepatic metastases (HM) that results from breast cancer has been controversially discussed. The aim of this study was to evaluate the outcome of LR in patients with hepatic breast cancer metastases.

Guardado en:
Detalles Bibliográficos
Autores principales: Hoffmann, Katrin (Autor) , Franz, Clemens (Autor) , Hinz, Ulf (Autor) , Schirmacher, Peter (Autor) , Herfarth, Christian (Autor) , Eichbaum, Michael H. R. (Autor) , Büchler, Markus W. (Autor) , Schemmer, Peter (Autor)
Formato: Article (Journal)
Lenguaje:inglés
Publicado: 09 February 2010
In: Annals of surgical oncology
Year: 2010, Volumen: 17, Número: 6, Pages: 1546-1554
ISSN:1534-4681
DOI:10.1245/s10434-010-0931-5
Acceso en línea:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1245/s10434-010-0931-5
Enlace del recurso
Notas de Autor:Katrin Hoffmann, Clemens Franz, Ulf Hinz, Peter Schirmacher, Christian Herfarth, Michael Eichbaum, Markus W. Büchler, and Peter Schemmer
Descripción
Sumario:Liver resection (LR) within a multimodal treatment concept of hepatic metastases (HM) that results from breast cancer has been controversially discussed. The aim of this study was to evaluate the outcome of LR in patients with hepatic breast cancer metastases.
Notas:Gesehen am 13.03.2023
Descripción Física:Online Resource
ISSN:1534-4681
DOI:10.1245/s10434-010-0931-5

Ejemplares similares